Amneal Pharmaceuticals, Inc.

DB:2DT Stock Report

Market Cap: €2.6b

Amneal Pharmaceuticals Future Growth

Future criteria checks 2/6

Amneal Pharmaceuticals is forecast to grow earnings and revenue by 156% and 5.6% per annum respectively. EPS is expected to grow by 156.7% per annum. Return on equity is forecast to be 78.5% in 3 years.

Key information

156.0%

Earnings growth rate

156.7%

EPS growth rate

Pharmaceuticals earnings growth20.4%
Revenue growth rate5.6%
Future return on equity78.5%
Analyst coverage

Low

Last updated11 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:2DT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,062N/A4013692
12/31/20252,876213403553
12/31/20242,760-712742313
9/30/20242,680-184229313N/A
6/30/20242,598-175176252N/A
3/31/20242,495-169124201N/A
12/31/20232,394-84276346N/A
9/30/20232,38610137186N/A
6/30/20232,312-2114199N/A
3/31/20232,272-135-584N/A
12/31/20222,212-130-2565N/A
9/30/20222,139-13253152N/A
6/30/20222,122-13480140N/A
3/31/20222,0982161214N/A
12/31/20212,09411189242N/A
9/30/20212,06714219285N/A
6/30/20212,0589176247N/A
3/31/20211,987-17408478N/A
12/31/20201,99391313379N/A
9/30/20201,88062183222N/A
6/30/20201,739-194283317N/A
3/31/20201,679-19971159N/A
12/31/20191,626-362-962N/A
9/30/20191,727-339200312N/A
6/30/20191,825-6797234N/A
3/31/20191,834-6919115N/A
12/31/20181,663-21153250N/A
9/30/20181,459155-4656N/A
6/30/20181,237149N/A67N/A
3/31/20181,083168N/A192N/A
12/31/20171,034168N/A234N/A
9/30/20171,03954N/A205N/A
12/31/20161,018207N/A115N/A
12/31/2015866169N/A105N/A
12/31/2014786177N/A112N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2DT is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 2DT is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 2DT is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 2DT's revenue (5.6% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: 2DT's revenue (5.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 2DT's Return on Equity is forecast to be very high in 3 years time (78.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y